NRO Neurones SA

Neurones: 6.3% net profit in 1st half 2025

Neurones: 6.3% net profit in 1st half 2025

PRESS INFORMATION

Heading: 1st half 2025 results        Nanterre, September 10, 2025 (after trading)

6.3% net profit in 1st half 2025

(in millions of euros)H1 20242024H1 2025 *
Revenues402.4810.4424.3
Business operating profit **40.5 (10.1%)84.1 (10.4%)37.4 (8.8%)
Operating profit37.1 (9.2%)77.9 (9.6%)33.1 (7.8%)
Net financial profit4.710.24.8
Income tax(12.6)(24.9)(11.1)
Net profit after tax29.2 (7.3%)63.2 (7.8%)26.8 (6.3%)
of which, group share24.552.522.7
Net cash excluding financial debt ***256.9319.5282.2
Staff at end of period (ppl)7,0017,0877,264

* Financial statements as of June 30, 2025, approved by the Board of Directors on September 10.

** Before cost of bonus shares.

*** Excluding IFRS16 lease liabilities.

Achievements

As previously announced, the Group posted growth of 5.4% in the first half of the year (including 4.6% with constant structures), despite an unfavorable economic environment.

At the end of the first half-year:

  • operating profit was confirmed at 7.8% after new social security and tax charges (approximately 0.4% of revenues). It mainly reflects pressure on gross margins (price pressure, slight increase in inter-contract periods, etc.);



  • net profit, group share, amounted to 5.3% of revenues;



  • net cash (excluding IFRS 16 lease liabilities) increased by €25.3 million compared to June 30, 2024.



Outlook

In a persistently uncertain climate, NEURONES confirms its latest forecasts for the full year:

  • revenues of nearly €850 million,
  • operating profit of approximately 8%.

About NEURONES

With over 7,250 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible



Press Relations:

O'Connection

Julia Philippe-Brutin

Tel.: +33 (0)6 03 63 06 03









NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37



Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37



Attachment



EN
10/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

Neurones: 6.3% net profit in 1st half 2025

Neurones: 6.3% net profit in 1st half 2025 PRESS INFORMATIONHeading: 1st half 2025 results        Nanterre, September 10, 2025 (after trading) 6.3% net profit in 1st half 2025 (in millions of euros)H1 20242024H1 2025 *Revenues402.4810.4424.3Business operating profit **40.5 (10.1%)84.1 (10.4%)37.4 (8.8%)Operating profit37.1 (9.2%)77.9 (9.6%)33.1 (7.8%)Net financial profit4.710.24.8Income tax(12.6)(24.9)(11.1)Net profit after tax29.2 (7.3%)63.2 (7.8%)26.8 (6.3%)of which, group share24.552.522.7Net cash excluding financial debt ***256.9319.5282.2Staff at end of period (ppl)7,0017,0877,264 * F...

 PRESS RELEASE

NEURONES : 6,3% de résultat net au 1er semestre 2025

NEURONES : 6,3% de résultat net au 1er semestre 2025 INFORMATION PRESSERubrique : Résultats 1er semestre 2025        Nanterre, le 10 septembre 2025 (après Bourse) 6,3% de résultat net au 1er semestre 2025 (en millions d’euros)S1 20242024S1 2025 *Chiffre d’affaires      402,4   810,4424,3Résultat opérationnel d’activité **40,5 (10,1%)    84,1 (10,4%)      37,4 (8,8 %)Résultat opérationnel37,1 (9,2%)    77,9 (9,6%)33,1 (7,8%)Produits financiers nets        4,7        10,24,8Impôt sur les résultats(12,6)   (24,9)(11,1)Résultat net après impôt       29,2 (7,3%)   63,2 (7,8%)26,8 (6,3%)dont p...

 PRESS RELEASE

NEURONES: Organic growth up 5.3% in 2nd quarter 2025

NEURONES: Organic growth up 5.3% in 2nd quarter 2025 PRESS INFORMATION        Nanterre, August 6, 2025 (after trading)Heading: 1st half 2025 revenues Organic growth up 5.3% in 2nd quarter 2025 Revenues (millions of euros)20242025Growthof which organicQ1204.9214.1+ 4.5%+ 3.9%Q2197.5210.2+ 6.4%+ 5.3%Total H1 revenues402.4424.3+ 5.4%+ 4.6% Achievements Organic growth of 5.3% in the second quarter was achieved in a more challenging economic environment. The most notable growth was in Data, Digital projects, market finance, ITSM (Service Now) solutions, and Business Process Management, with t...

 PRESS RELEASE

NEURONES : + 5,3% de croissance organique au 2e trimestre 2025

NEURONES : + 5,3% de croissance organique au 2e trimestre 2025 INFORMATION PRESSE        Nanterre, le 6 août 2025 (après Bourse)Rubrique : C.A. 1er semestre 2025 + 5,3% de croissance organique au 2e trimestre 2025 C.A. (en millions d’euros)20242025Croissancedont organique1er trimestre204,9214,1+ 4,5%+ 3,9%2e trimestre197,5210,2+ 6,4%+ 5,3%Total 1er semestre402,4424,3+ 5,4%+ 4,6% Réalisations A 5,3%, la croissance organique du deuxième trimestre a été réalisée dans des conditions économiques plus tendues. Les progressions les plus notables concernent la Data, les projets Digitaux, la fina...

 PRESS RELEASE

NEURONES : Descriptif du programme de rachat d'actions

NEURONES : Descriptif du programme de rachat d'actions INFORMATION PRESSERubrique : Rachat d’actions                                         Nanterre, le jeudi 5 juin 2025 (après Bourse) DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS L’Assemblée Générale des actionnaires du 5 juin 2025 a renouvelé l’autorisation consentie au Conseil d’administration, pour une durée de 18 mois, de procéder à l’achat des propres actions de la société. Etabli en application de l’article 241-2 et suivants du Règlement général de l’AMF, le présent descriptif précise les modalités et les objectifs du programme d...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch